Stock A354200 NGENEBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News NGeneBio Co., Ltd.

Equities

A354200

KR7354200008

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
3,965 KRW -0.50% Intraday chart for NGeneBio Co., Ltd. -6.38% -28.69%
Apr. 22 NGENEBIO USA Holdings, INC. announced that it expects to receive KRW 3.7395 billion in funding from NGeneBio Co., Ltd. CI
Apr. 15 J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NGENEBIO USA Holdings, INC. announced that it expects to receive KRW 3.7395 billion in funding from NGeneBio Co., Ltd.
CI
J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion.
CI
J&L Agent Co., Ltd. and other buyer agreed to acquire 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3.2 billion.
CI
NGENEBIO USA HOLDINGS, INC., announced that it has received KRW 4.0161 billion in funding from NGeneBio Co., Ltd.
CI
South Korea's NGeneBio Joins CancerX Partnership
MT
MGI Tech Co., Ltd. Partners with NGeneBio Co., Ltd. to Advance Precision Medicine
CI
NGeneBio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
NGeneBio Co., Ltd.(KOSDAQ:A354200) dropped from S&P Global BMI Index
CI
NGeneBio Co., Ltd. announced that it has received KRW 20 billion in funding from SK Securities Co., Ltd., Investment Arm, Shinhan Investment Corp., Investment Arm, and other investors.
CI
NGeneBio Co., Ltd. announced that it expects to receive KRW 20 billion in funding from SK Securities Co., Ltd., Investment Arm, Shinhan Investment Corp., Investment Arm, and other investors.
CI
NGeneBio Co., Ltd.(KOSDAQ:A354200) added to S&P Global BMI Index
CI
NGeneBio Co., Ltd. has completed an IPO in the amount of KRW 34.216 billion.
CI
NGeneBio Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A354200 Stock
  4. News NGeneBio Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW